The injected medication fremanezumab, brand name Ajovy, which is used to prevent migraine headaches in adults, also reduces comorbid depression symptoms, according to a 28-week randomized clinical trial. The trial compared the effectiveness of fremanezumab with a placebo in reducing the average number of monthly migraine days and depressive symptoms. At the start of the trial, each of the 353 participants had migraine and active symptoms of comorbid major depressive disorder.

During the study, those who received the active medication as a monthly injection over 12 weeks had 5.1 fewer migraine days, compared to 2.9 fewer for . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Injected Medication To Prevent Migraine Also Reduces Comorbid Depression

The injected medication fremanezumab, brand name Ajovy, which is used to prevent migraine headaches in adults, also reduces comorbid depression symptoms, according to a 28-week randomized clinical trial. The trial compared the effectiveness of fremanezumab with a placebo in reducing the average number of monthly migraine days and depressive symptoms. At the start of the trial, each of the 353 participants had migraine and active symptoms of comorbid major depressive disorder.

During the study, those who received the active medication as a monthly injection over 12 weeks had 5.1 fewer migraine days, compared to 2.9 fewer for . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.